2003

Coinfected patients may require longer HCV treatment, irrespective of genotype

1 November 2003. Related: Hepatitis coinfection.

New recommended standards of care for NHS services

1 November 2003. Related: Other news.

Vatican says HIV can pass through condoms

1 November 2003. Related: Other news.

Conferences

1 November 2003. Related: On the web.

Newsletters and reports

1 November 2003. Related: On the web.

HIV and hepatitis coinfection

1 November 2003. Related: On the web.

Volume 4 Number 9 November 2003 PDF

1 November 2003. Related: PDFs.

Volume 4 Number 8 October 2003

1 October 2003. Related: Editorial.

Important new pharmacokinetic data for atazanavir sulfate (Reyataz) in combination with tenofovir disoproxil fumarate (Viread)

1 October 2003. Related: Treatment alerts.

British 2003 HIV treatment guidelines are published online

1 October 2003. Related: Guidelines.

South Africa delays deregistering nevirapine

1 October 2003. Related: Treatment access.

Disagreement greets a new deal on patent protection and generic drugs for poor countries

1 October 2003. Related: Treatment access.

TRIPS agreement will not save lives

1 October 2003. Related: Treatment access.

Joint statement by 14 NGOs dismisses TRIPS deal as a ‘gift bound in red tape’

1 October 2003. Related: Treatment access.

An activist’s view from the WTO meeting in Cancun

1 October 2003. Related: Treatment access.

South African cabinet rules that public hospitals should provide ARVs

1 October 2003. Related: Treatment access.

Indian government taken to court over lack of treatment

1 October 2003. Related: Treatment access.

43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 14-17 September 2003, Chicago

1 October 2003. Related: Conference reports.

South African AIDS Conference, 3-6 August 2003, Durban

1 October 2003. Related: Conference reports.

Township project is a model for care in resource poor settings

1 October 2003. Related: Conference reports, Treatment access.

Projects band together to buy lowest-cost generic drugs

1 October 2003. Related: Conference reports, Treatment access.

MTCT-Plus operates in Cote D’Ivoire, Kenya, Mozambique, Rwanda, South Africa, Thailand, Uganda and Zambia

1 October 2003. Related: Conference reports, Pregnancy.

Further reports from 2nd IAS Conference on HIV Pathogenesis and Treatment, Paris, 13-16 July 2003

1 October 2003. Related: Conference reports.

New atazanavir information

1 October 2003. Related: Conference reports, Antiretrovirals.

Boosted PI therapy antiretrovirals in treatment-experienced patients: SQV/r, ATV, ATV/r

1 October 2003. Related: Conference reports, Antiretrovirals.

HIV viral dynamics: viral fitness, genetic diversity, progression, co-receptor use

1 October 2003. Related: Conference reports, Basic science and immunology, Virology.

Pulmonary hypertension: finally a treatment trial!

1 October 2003. Related: Conference reports, Virology.

New guidelines for the evaluation and management of dyslipidaemia in HIV patients on HAART (2003)

1 October 2003. Related: Lipodystrophy and metabolic complications.

Treatments for lipoatrophy. Are there improvements? Are they noticeable?

1 October 2003. Related: Lipodystrophy and metabolic complications.

Rosiglitazone significantly increases triglyceride and cholesterol levels and does not improve HAART-associated lipoatrophy

1 October 2003. Related: Lipodystrophy and metabolic complications.

US approves and Europe rejects Serostim (recombinant growth hormone) for treatment of HIV-related wasting

1 October 2003. Related: Lipodystrophy and metabolic complications.

Testosterone therapy prevents loss of lean body mass, improves mood and libido in HIV positive women and increases bone mineral density in HIV positive men

1 October 2003. Related: Side effects.

Only time with HIV infection and not specific antiretroviral therapy is associated with decreased bone mineral density

1 October 2003. Related: Side effects.

IL-2 induced increases in CD4 counts are blunted by use of prednisone

1 October 2003. Related: Basic science and immunology.

Treatment interruption shows no benefit in drug-resistant HIV infection

1 October 2003. Related: Treatment strategies.

Postnatal transmission of HIV to breastfed infants following short course ZDV regimen

1 October 2003. Related: Pregnancy.

Subtype differences in mother to child transmission

1 October 2003. Related: Pregnancy.

Influence of mothers’ health and survival on children’s survival

1 October 2003. Related: Pregnancy.

Higher than currently recommended NVP dose shows greater efficacy in HIV-infected children

1 October 2003. Related: Paediatric care.

Time on anti-HIV therapy is a protective factor for liver fibrosis in HIV-HCV coinfected patients

1 October 2003. Related: Hepatitis coinfection.

HIV-HCV co-infected patients have poorer response to HCV therapy

1 October 2003. Related: Hepatitis coinfection.

CDC study shows rifampin/pyrazinamide therapy can cause severe liver damage

1 October 2003. Related: TB coinfection.

Impact of the HIV epidemic in sub-Saharan Africa on the pattern of HIV in the UK

1 October 2003. Related: Other news.